Additional Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    Dignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic Institute
    Phoenix AZ. 85013
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    CHI Health Creighton University Medical Center - Bergan Mercy
    Omaha NE. 68124
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    University of Illinois Health
    Chicago IL. 60612
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    Baylor University Medical Center
    Dallas TX. 75246
    View Details

  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    Indiana University Health Methodist Hospital
    Indianapolis IN. 46202
    View Details

  • Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis

    Snyder Building 480 Ray C. Hunt Drive
    Charlottesville VA. 22908
    View Details

  • NAL ER IPF Respiratory Function and Safety Study

    Mayo Clinic
    Rochester MN. 55905
    View Details

  • Inspiratory Work of Breathing Before and After Extubation

    Toronto General Hospital, University Health Network
    Toronto ON. M5G2C4
    View Details

  • Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis

    Weill Cornell Medicine
    New York NY. 10065
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Palm Springs, CA
    Palm Springs CA. 92203
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Greensboro, NC
    Greensboro NC. 27403
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Shreveport, LA
    Shreveport LA. 71103
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Ajax, ON
    Ajax ON. L1S 2J5
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Phoenix, AZ
    Phoenix AZ. 85032
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Champaign, IL
    Champaign IL. 61822
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Loxahatchee, FL
    Loxahatchee FL. 33470
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Newport Beach, CA
    Newport Beach CA. 92663
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Texas Southwestern
    Dallas TX. 75390
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Virginia
    Charlottesville VA. 22908
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Michigan
    Ann Arbor MI. 48109
    View Details